The Congress is sponsored by the International Society of Healthcare Ethics and Compliance Professionals (ETHICS), the Pharmaceutical Compliance Forum (PCF), the Pharmaceutical and Healthcare Association of the Philippines (PHAP) and the Philippine Alliance of Patient Organizations (PAPO).
The Congress is the leading pharma compliance event in Asia Pac. In the past it has been offered in Singapore (2011), Shanghai (2012), Kuala Lumpur (2013) and Shanghai (2014). The Congress is a part of a global pharma compliance congress series which has featured recent congress in Dubai and Brussels (the International Pharma Compliance Congress), Sao Paolo and Mexico City (the Latin American Pharma Congress) and Washington, DC (the Pharma Congress).
The Asia Pacific region is geographically immense and culturally, economically and politically diverse. Many countries in the region are experiencing explosive economic growth. As the Asia Pacific region rises so does its importance to the global pharmaceutical, device and life sciences sectors.
The life sciences industry in Asia Pacific has been growing at breakneck speed. The law and regulations surrounding the industry, as well as industry codes of practice, have been increasing exponentially. Certainty and consistency in the application of these new laws, regulation and codes, so important to efficient business practices, has been uneven. These developments challenge companies to adapt, change and evolve faster to be able to respond with new internal processes and behaviors. The UK Bribery Act joins the FCPA and various Asia Pacific anti-corruption laws now applicable to business in the region. There has also recently been intense regulatory enforcement focus on the industry by various Asian governments in order to create a more transparent environment and provide consistent guidelines to HCPs and companies on how to interact without having undue influence. These investigations and enforcement actions present increasing risks for many companies and HCPs which are still trying to find their footing in this complex and booming region.
The Congress will be offered immediately prior to the Asia-Pacific Economic Cooperation (APEC) 2nd Business Ethics for Small and Medium Size Enterprises (SME) Forum, August 19 - 20, 2015, in Manila, Philippines. APEC is a forum for 21 Pacific Rim member economies that promotes free trade throughout the Asia-Pacific region. The APEC Forum will bring together its pharma working group to work with stakeholders on the implementation of the APEC Principles for Voluntary Codes of Business Ethics in the Biopharmaceutical Sector, known as the "Mexico City Principles", and the medical device working group to work with stakeholders on the implementation of the Nanjing Declaration to Promote Ethical Business Practices in the Medical Device and Biopharmaceutical Sectors (2014-2020), known as the "Nanjing Declaration".
The Congress and Forum will jointly sponsor a reception on the evening of Tuesday, August 18 (the Congress closing reception and the Forum opening reception).
WHO SHOULD ATTEND
- Pharmaceutical Manufacturers
- Generic Pharmaceutical Manufacturers
- Site Management Organizations
- Clinical Research Organizations
- Management Companies
- Wholesale, Retail, Mail Order and Internet Pharmacies
- Health Care Regulators and Policy Makers
- Pharmaceutical and Health Care Professionals
- Executives and Board Members
- Regulatory and Compliance Professionals
- Medical Directors
- Food and Drug Law Attorneys
- Health Care Attorneys
- In-house Counsel
- Compliance Officers
- Privacy Officers
- Ethics Officers and Corporate Social Responsibility Personnel
- Pharmaceutical Consultants
- Investment Bankers
- Venture Capitalists
- Health Services Researchers and Academics
- Promotion Signatories/Approvers
- Risk Management Personnel
ABOUT THE COSPONSORS
The International Society of Healthcare Ethics and Compliance Professionals (ETHICS) is a forum for open dialogue and exchange among Compliance and Ethics professionals in the Healthcare industry. The Association's activities are sustained by one transverse and permanent objective: support professionals in Compliance and Ethics in Healthcare industry to develop and better manage their role and duties -- without any sort of commercial benefit for the Association or any of its members.
The Pharmaceutical Compliance Forum (PCF) is a coalition of senior compliance professionals and legal counsel from more than 50 of the largest research-based pharmaceutical manufacturers. The PCF was founded in early-1999 by compliance professionals from the pharmaceutical industry to promote effective corporate compliance programs. www.pharmacomplianceforum.org.
The Pharmaceutical and Healthcare Association of the Philippines (PHAP) and it's 56 member companies represent the research -based and pharmaceutical and healthcare industry, a key sector in the never ending fight for improved health through the continuous development of new, better, more efficacious and cost-effective drug therapies.
The Philippine Alliance of Patient Organizations (PAPO) is the umbrella organization of all the patient groups in the Philippines. It is an affiliate of the International Alliance of Patient Organizations.